CastleVax is a human-centered biotech focused on developing safe, effective, efficient, and affordable vaccines that are accessible to all individuals.
CastleVax is grateful to continue our clinical development efforts under BARDA’s Project NextGen of our innovative, next-generation, mucosal COVID-19 vaccine to protect against breakthrough infection and transmission https://t.co/CIORPXTOfV
@BARDA & Johnson & Johnson Innovation are proud to congratulate the #BLUEKNIGHT#ProjectNextGen#QuickFireChallenge awardees! BARDA will provide the awardees grant funding from a total pool of $10M. Learn more about these innovative companies: https://t.co/f9h2FbJS71
Meet the @BARDA and Johnson & Johnson Innovation, Blue Knight Resident QuickFireChallenge: Accelerating Project NextGen awardees!
Learn more: https://t.co/IeRMPrJYnP
We are thrilled to be announced as one of the awardees for the #BLUEKNIGHT#QuickFireChallenge. Looking ahead with great anticipation to continue innovating for a better and safer future.
We are pleased to share that interim Phase 3 results from our partner @AvimexLab showed their NDV-based vaccine (licensed from CastleVax) was an effective booster against COVID-19.
https://t.co/YjxNLwqzrD
During the White House Summit on the Future of COVID-19 Vaccines this week, Dr. Fauci highlighted the importance of developing next generation vaccines. We were thrilled to see the work of our scientific co-founder, @florian_krammer, featured during the presentation! (56:00)
HAPPENING NOW: Tune in here for the White House Summit on the Future of COVID-19 Vaccines, hosted by Dr. Ashish Jha and the White House COVID-19 Response Team. https://t.co/9jS5EdQKlP
Introducing, CastleVax!
We are a pioneering clinical-stage vaccine platform, reimagining how to provide safe and effective vaccines for all humans, everywhere.
We invite you to follow our page & stay tuned as we make waves.
https://t.co/13h3A2Jqil
#vaccinedevelopment